Pacira Pharmaceuticals (NASDAQ:PCRX)
| CAPS Rating |
|
|---|
PCRX
VS S&P 500 (SPY)
PCRX News and Commentary
- 10 Stocks Favored By Hedge Funds And Company Insiders – SeekingAlpha
- NASDAQ Changes Up Biotech Index Members & Weightings – 247wallst
- Pacira Pharmaceuticals Misses Where It Counts – The Motley Fool
- Registration Effectiveness Orders Issued By The SEC – SmartMoney
- Groupon Fail: What Other IPOs Are Tanking? – The Motley Fool
- Hidden Stocks for High Returns – The Motley Fool
- Registration Effectiveness Orders Issued By The SEC – SmartMoney
- FDA Watch: 6 Biotechs Awaiting FDA Drug Approvals in 2011 – NASDAQ
- Stocks Rally as Retail Sales Top Street; Deal Activity Also Adds Lift – NASDAQ
How do you think PCRX will perform against the market?
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
16
Outperform
2
Underperform
All-Star Players
6
Outperform
1
Underperform
Wall Street
3
Outperform
0
Underperform
RSS Headlines
Fool UK
